Evaluating the Impact of Psychotherapeutic Advertising Claims on Cannabis Purchasing

NANot yet recruitingINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

January 30, 2026

Primary Completion Date

May 30, 2026

Study Completion Date

July 31, 2026

Conditions
AnxietyDepressionCannabis Use
Interventions
BEHAVIORAL

CC

Participants are exposed to an online cannabis store condition that includes claims about neutral product attributes.

BEHAVIORAL

PAC

"Participants are exposed to an online cannabis store condition that includes CC plus claims about each product's effects on mental health (e.g., Calming) and symptom relief (e.g., Helps with: Stress)."

BEHAVIORAL

WL

Includes CC plus a mental health warning label about the negative impact of THC on anxiety and depression.

Trial Locations (1)

03766

Center for Technology and Behavioral Health (CTBH), Geisel School of Medicine at Dartmouth College, Lebanon

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Trustees of Dartmouth College

OTHER

NCT07216911 - Evaluating the Impact of Psychotherapeutic Advertising Claims on Cannabis Purchasing | Biotech Hunter | Biotech Hunter